Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,729
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Chapel Hill NC, Atlanta GA, Baltimore MD, Hershey PA,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase3, Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Chapel Hill NC, Charlotte NC, Summerville SC,
Location: Chapel Hill NC, Kingsport TN, Charleston SC,
Sponsor: Cook Research Incorporated
Sex: All
Age: 18+
Code: NCT04875429
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
for
Clinical High Risk for Psychosis (CHR)
Location: Chapel Hill NC, Pittsburgh PA, Columbus OH,
Sponsor: Monument Therapeutics Limited
Sex: All
Age: 17 - 30
Code: NCT07226895
Phase1, Phase2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Chapel Hill NC, Durham NC, Atlanta GA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Chapel Hill NC, Charlotte NC, Charlottesville VA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase3, Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Advanced Renal Cell Carcinoma (aRCC),
Location: Chapel Hill NC, Washington D.C. DC, Hershey PA,
Sponsor: Brian Rini
Sex: All
Age: 18+
Code: NCT07188896
Phase2, Recruiting
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
for
Refractory Melanoma
Location: Chapel Hill NC, Birmingham AL, Morristown NJ, Boston MA,
Sponsor: Diakonos Oncology Corporation
Sex: All
Age: 18+
Code: NCT07288112
Phase1, Phase2, Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Chapel Hill NC, Charleston SC, Cincinnati OH,
Sponsor: Rein Therapeutics
Sex: All
Age: 40+
Code: NCT06968845
Phase2, Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Chapel Hill NC, Greenville NC, Wilmington NC,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase2, Recruiting
Maternal Newborn Health Registry
for
Pregnancy Outcome Trends in Low-resource Geographic Areas
Location: Chapel Hill NC, Charlottesville VA, Philadelphia PA,
Sponsor: NICHD Global Network for Women's and Children's Health
Sex: All
Age: 0+
Code: NCT01073475
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
for
Squamous Cell Carcinoma of Head and Neck
Location: Chapel Hill NC, Atlanta GA, Philadelphia PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 18 - 70+
Code: NCT07219212
Phase1, Recruiting
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
for
Relapsed Acute Myeloid Leukemia (AML),
Location: Chapel Hill NC, Columbus OH, Philadelphia PA,
Sponsor: Auron Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06846606
Phase1, Recruiting
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
for
Bladder Cancer, Recurrent Bladder Cancer,
Location: Chapel Hill NC, Columbus OH, Nashville TN, Tampa FL,
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07225127
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for
Acute Myeloid Leukemia (AML)
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07007312
Phase3, Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Chapel Hill NC, Baltimore MD, Jacksonville FL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase1, Recruiting
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
for
Obesity, Cancer, Physical Activity, Cancer Survivorship, Diet
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center